Therapeutic agent for disc herniation
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 11, 2016
Grant Date -
Mar 12, 2015
app pub date -
Sep 19, 2014
filing date -
Dec 13, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a therapeutic agent for disc herniation, which has extremely few adverse side effects, can achieve a prolonged pain-ameliorating effect when administered in only a single dose, and can exhibit a high therapeutic effect and high safety in clinical applications. The present invention relates to a therapeutic agent for disc herniation, which is characterized by containing chondroitinase ABC as an active ingredient and being administered in such a manner that the ingredient can be administered into a human disk in an amount of 1-8 units per disk.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully